Medicare Benefits Schedule - Item 35614

Examination of the lower genital tract using a colposcope in a patient who:
(a) has a human papilloma virus related gynaecology indication; or
(b) has symptoms or signs suspicious of lower genital tract malignancy; or
(c) is undergoing follow-up treatment of lower genital tract malignancy; or
(d) is undergoing assessment or surveillance of a vulvovaginal pre-malignant or malignant disease; or
(e) is undergoing assessment or surveillance as part of an identified at risk population

Multiple Operation Rule

Fee: $67.50 Benefit: 75% = $50.65 85% = $57.40

(See para TN.8.42, TN.8.233 of explanatory notes to this Category)

• Previous - Item 35612
• Next - Item 35615

It should be noted that colposcopic examination (screening) of a person during the course of a consultation does not attract Medicare benefits under Item 35614 except in the following circumstances:  

(a) where the patient has had an abnormal cervical screen result;

(b) where there is a history of ingestion of oestrogen by the patient's mother during their pregnancy;  or

(c) where the patient has been referred by another medical practitioner because of suspicious signs of genital cancer.

Related Items: 35614

The procedure should only be performed if a patient satisfies the criteria according to the current National Cervical Screening Program.

Related Items: 35609 35610 35614 35647 35648 35723 35724